Quantcast
Home > Quotes > MYL
MYL

Mylan N.V. Ordinary Shares (MYL) Quote & Summary Data

$34.13
*  
1.63
4.56%
Get MYL Alerts
*Delayed - data as of Nov. 14, 2018 14:50 ET  -  Find a broker to begin trading MYL now
Exchange:NASDAQ
Industry: Health Care
Community Rating:
View:    MYL Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Key Stock Data

Best Bid / Ask
$ 34.13 / $ 34.14
1 Year Target
43
Today's High / Low
$ 36.09 / $ 34.04
Share Volume
5,050,763
50 Day Avg. Daily Volume
5,180,282
Previous Close
$ 35.76
52 Week High / Low
$ 47.82 / $ 30.33
Market Cap
17,598,502,788
P/E Ratio
32.82
Forward P/E (1y)
7.68
Earnings Per Share (EPS)
$ 1.04
Annualized Dividend
$ 0.24
Ex Dividend Date
Mar. 28, 2007
Dividend Payment Date
Apr. 16, 2007
Current Yield
0.67 %
Beta
1.38

Intraday Chart

Shares Traded

Share Volume:
5,050,763
50 Day Avg. Daily Volume:
5,180,282

P/E Ratio

P/E Ratio:
32.82
Forward P/E (1y):
7.68
Earnings Per Share (EPS):
$ 1.04

Trading Range

The current last sale of $34.13 is 12.53% Higher than the 52 week low.

Intraday Last 52 Weeks
High: $ 36.09 $ 47.82
 Low: $ 34.04 $ 30.33

ETFs with MYL as a Top 10 Holding*

Weighting ETF Name (Symbol) 100-Day Price Change (%)
5.21% VanEck Vectors Generic Drugs ETF (GNRX) -1.19 (-4.77%)
3.89% First Trust Nasdaq Pharmaceuticals ETF (FTXH) +0.20 (0.93%)
3.39% iShares U.S. Pharmaceutical ETF (IHE) -0.80 (-0.52%)
2.61% iShares Nasdaq Biotechnology Index Fund (IBB) -8.20 (-7.31%)
1.98% Invesco Zacks Mid-Cap ETF (CZA) -0.66 (-1.00%)
*Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change.
**Green highlights the top performing ETF by % change in the past 100 days.

Company Description (as filed with the SEC)

Mylan N.V., along with its subsidiaries (collectively, the "Company," "Mylan," "our" or "we"), is a leading global pharmaceutical company, which develops, licenses, manufactures, markets and distributes generics, branded generics, brand name and over-the-counter ("OTC") products in a variety of dosage forms and therapeutic categories. Mylan is committed to setting new standards in healthcare by creating better health for a better world, and our mission is to provide the world's 7 billion people access to high quality medicine. To do so, we innovate to satisfy unmet needs; make reliability and service excellence a habit; do what's right, not what's easy; and impact the future through passionate global leadership. We believe access to healthcare should be a right, not a privilege. That makes our mission very personal. While a great deal of progress has been made over the years to expand access to healthcare, there's still much to be done.  ... More ...  


Risk Grade

Where does MYL fit in the risk graph?


Risk Grade Scale

Nasdaq Official Price

Open Price:
$ 35.87
Open Date:
Nov. 14, 2018
Close Price:
$ 35.76
Close Date:
Nov. 13, 2018

Consensus Recommendation

Analyst Info



Another Bailout?? Why is the SEC boosting big banks and HFT's bottom lines?
x